Pharmaceutical applications of hot-melt extrusion: Part II

被引:299
作者
Repka, Michael A. [1 ]
Battu, Sunil Kumar
Upadhye, Sampada B.
Thumma, Sridhar
Crowley, Michael M.
Zhang, Feng
Martin, Charles
McGinity, James W.
机构
[1] Univ Mississippi, Sch Pharm, Dept Pharmaceut, University, MS 38677 USA
[2] PharmaForm LLC, Austin, TX USA
[3] Amer Leistritz Extruder Corp, Somerville, NJ USA
[4] Univ Texas, Coll Pharm, Div Pharmaceut, Austin, TX 78712 USA
关键词
hot-melt extrusion; solid dispersion; bioavailability; melt-extruded tablets; drug delivery systems; melt extruded films;
D O I
10.1080/03639040701525627
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The advent of high through-put screening in the drug discovery process has resulted in compounds with high lipophilicity and poor solubility. Increasing the solubility of such compounds poses a major challenge to formulation scientists. Various approaches have been adopted to address this including preparation of solid dispersions and solid solutions. Hot-melt extrusion is an efficient technology for producing solid molecular dispersions with considerable advantages over solvent-based processes such as spray drying and co-precipitation. Hot-melt extrusion has been demonstrated to provide sustained, modified, and targeted drug delivery. Improvements in bioavailability utilizing the hot-melt extrusion technique demonstrate the value of the technology as a potential drug delivery processing tool. The interest in hot-melt extrusion technology for pharmaceutical applications is evident from the increasing number of patents and publications in the scientific literature. Part II of this article reviews the myriad of hot-melt extrusion applications for pharmaceutical dosage forms including granules, pellets, tablets, implants, transmucosal, and transdermal systems.
引用
收藏
页码:1043 / 1057
页数:15
相关论文
共 67 条
[1]   Hot melt extrusion of acrylic films [J].
AitkenNichol, C ;
Zhang, F ;
McGinity, JW .
PHARMACEUTICAL RESEARCH, 1996, 13 (05) :804-808
[2]   In vitro evaluation of poly(D,L-lactide-co-glycolide) polymer-based implants containing the alpha-melanocyte stimulating hormone analog, Melanotan-I [J].
Bhardwaj, R ;
Blanchard, J .
JOURNAL OF CONTROLLED RELEASE, 1997, 45 (01) :49-55
[3]   In vitro characterization and in vivo release profile of a poly(D,L-lactide-co-glycolide)-based implant delivery system for the α-MSH analog, melanotan-I [J].
Bhardwaj, R ;
Blanchard, J .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1998, 170 (01) :109-117
[4]   Melt extrusion: from process to drug delivery technology [J].
Breitenbach, J .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2002, 54 (02) :107-117
[5]   Properties of hot-melt extruded tablet formulations for the colonic delivery of 5-aminosalicylic acid [J].
Bruce, LD ;
Shah, NH ;
Malick, AW ;
Infeld, MH ;
McGinity, JW .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2005, 59 (01) :85-97
[6]   The influence of guaifenesin and ketoprofen on the properties of hot-melt extruded polyethylene oxide films [J].
Crowley, MM ;
Fredersdorf, A ;
Schroeder, B ;
Kucera, S ;
Prodduturi, S ;
Repka, MA ;
McGinity, JW .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2004, 22 (05) :409-418
[7]   Stability of polyethylene oxide in matrix tablets prepared by hot-melt extrusion [J].
Crowley, MM ;
Zhang, F ;
Koleng, JJ ;
McGinity, JW .
BIOMATERIALS, 2002, 23 (21) :4241-4248
[8]  
CROWLEY MM, 2004, INT J PHARM, V27, P77
[9]   Bioavailability of ibuprofen from hot-melt extruded mini-matrices [J].
De Brabander, C ;
Vervaet, C ;
Van Bortel, L ;
Remon, JP .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 271 (1-2) :77-84
[10]   EVALUATION OF HOT-MELT EXTRUSION AS A NEW TECHNIQUE FOR THE PRODUCTION OF POLYMER-BASED PELLETS FOR SUSTAINED-RELEASE CAPSULES CONTAINING HIGH LOADINGS OF FREELY SOLUBLE DRUGS [J].
FOLLONIER, N ;
DOELKER, E ;
COLE, ET .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1994, 20 (08) :1323-1339